ArticleLeukemia2010

Treatment of patients with relapsed/refractory multiple myeloma with lenalidomide and dexamethasone with or without bortezomib: prospective evaluation of the impact of cytogenetic abnormalities and of previous therapies.

M A Dimopoulos et al.PubMed ↗Publisher ↗

No numbers read from the abstract.